Oncology PracticeHurricanes delay RT, worsening survival of NSCLCJuly 23, 2019Lung CancerPatient & Survivor Care
Oncology PracticeInvestigators target brain metastases in NSCLCJuly 16, 2019Lung CancerCNS/Brain Cancer
Oncology PracticeAtezolizumab combo in first-line NSCLC misses cost-effectiveness markJuly 16, 2019Lung CancerPractice Management
Predicting outcomes in acute leukemia, NSCLCJuly 8, 2019ALLLeukemia, Myelodysplasia, TransplantationLung Cancer
Oncology PracticeVemurafenib has durable activity in NSCLC harboring BRAF V600 mutationsJuly 2, 2019Lung Cancer
Oncology PracticeMultigene panel sequencing is moderately cost-effective in NSCLCJuly 1, 2019Lung CancerPractice Management
Oncology PracticeFDA approves bevacizumab-bvzr for several cancersJune 28, 2019Gynecologic CancerRenal Cell CarcinomaLung CancerGastroenterologyGenitourinary CancerCNS/Brain CancerNeuro-oncology
Oncology PracticeLiquid biopsy assays found sensitive for NSCLC EGFR mutationsJune 24, 2019Lung Cancer
Oncology PracticeImmunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indicationsJune 24, 2019Lung CancerPatient & Survivor Care
Chemo-free neoadjuvant approaches emerge in NSCLC and breast cancerJune 21, 2019Lung CancerBreast CancerImmuno-oncology
Oncology PracticeNeoadjuvant-adjuvant erlotinib shows promise in locally advanced NSCLCJune 17, 2019Lung Cancer
